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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S122media. Neither fatty acids nor TNFa were cytotoxic. The increase in COX2
gene expression of cultured chondrocytes in response to TNFa was coun
teracted by DHA (p<0.05) and oleic acid (p<0.05). MMP1 expression was
also increased in response to TNFa and this effect was counteracted by
oleic acid (p<0.05) and palmitic acid (p<0.05). GAG release by cartilage
explants was decreased when cultured in oleic acid (p<0.05). Gene
expression of MMP3, MMP13 and ADAMTS4 in cell cultures and NO
production by cartilage explants did not signiﬁcantly change in response to
any fatty acid. Exposure of chondrocytes and explants to linoleic acid (n 6)
in absence or presence of TNFa did not inﬂuence any of the parameters
measured.
Conclusions: DHA (n 3), oleic acid (n 9), and palmitic acid (saturated) are
able to counteract some of the effects induced by TNFa in cartilage
explants or chondrocyte cultures. This was already known for DHA, but
reported for the ﬁrst time for oleic acid and palmitic acid.
Since fatty acids inﬂuence inﬂammation and degradation of cartilage, they
can be regarded potential therapeutic targets in OA prevention and
treatment.
Figure1. The effect of fatty acids on COX2 gene expression in chondrocytes
in absence or presence of 10 ng/ml TNFa (n¼6, from 2 donors).
Acknowledgment: This study was performed within the framework of the Dutch Top Institute
Pharma project #T1-213.
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THROMBIN AND PLASMIN INDUCED PROTEOGLYCAN RELEASE IN
HUMAN CARTILAGE IS PAR DEPENDENT
L. Nieuwenhuizen, R.E. Schutgens, G. Roosendaal, S.C. Mastbergen,
D.H. Biesma, F.P. Lafeber. Univ. Med. Ctr. Utrecht, Utrecht, Netherlands
Purpose: Osteoarthritis (OA) and Rheumatoid Arthrisis (RA) are charac
terized by degradation of the cartilage. Proteases of the coagulation
cascade and the ﬁbrinolytic system, such as thrombin and plasmin, are
elevated in both plasma and synovial ﬂuid of OA and RA patients and are
able to induce cartilage degradation. Cross talking between coagulation
and inﬂammation is mediated by protease activated receptors (PARs),
which are expressed at increased level in OA and RA cartilage. These
receptors are activated through cleavage by serine proteases, such as
thrombin and plasmin. RNA interference is a process inwhich genes can be
silenced sequence speciﬁc. This can be invoked by transfection of tissue/
cells with small interfering RNA (siRNA). Our aimwas to study whether the
thrombin and plasmin induced cartilage damage in human cartilage was
PAR dependent.
Methods: Full thickness OA human articular cartilage tissue was
obtained during total knee surgery. Slices of cartilage were cut asepti
cally from the articular surface. Within 1 hour of dissection the sliceswere cut into square pieces, weighed aseptically (range, 5.0 to 15.0 mg)
and each sample was individually put into culture. Cartilage was
cultured for 4 days in the presence of different concentrations thrombin
(10, 30, or 100nM), or plasmin (10, 30, or 100nM). In addition, cartilage
was transfected with PAR1 4 small interfering RNA (600nM) or control
siRNA (600nM), and cultured with thrombin (100nM) or plasmin
(100nM). Cartilage matrix turnover, in terms of proteoglycan release,
was determined at day 4. To investigate the silencing effect of the siRNA
transfection, cartilage RNA was extracted and PAR1 4 mRNA expression
was analyzed with RT PCR.
Results: Thrombin and plasmin increased proteoglycan release in human
cartilage in a dose dependent and statistically signiﬁcant manner (500%
for thrombin at 100nM; 217% for plasmin at 100nM). Thrombin and
plasmin induced proteoglycan release was statistically signiﬁcant reduced
with PAR1 4 siRNA (60% for thrombin at 100nM; 54% for plasmin at
100nM). Control siRNA failed to reduce thrombin and plasmin induced
proteoglycan release. Transfectionwith PAR1 4 siRNA resulted in complete
suppression of PAR1 4 mRNA expression, whereas no effect of control
siRNA on PAR1 4 mRNA expression was noted.
Conclusions: These results demonstrate for the ﬁrst time that thrombin
and plasmin induced proteoglycan release in human cartilage is PAR
dependent and offer promise for the use of siRNA as a new strategy for
therapeutic intervention in OA and RA.
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BONE SIALOPROTEIN : A KEY MEDIATOR OF THE ANGIOGENIC ACTIVITY
OF HYPERTROPHIC OSTEOARTHRITIC CHONDROCYTES
L. Pesesse 1, C. Sanchez 1, C. Baudouin 2, P. Msika 2, Y. Henrotin 1. 1Univ. of
Liege, Liege, Belgium; 2 Laboratoires ExpanSci., IRD Direction, Epernon, France
Purpose: Hypertrophic differentiation of chondrocytes in osteoarthritis
(OA) is a pathological process leading to vascularization and mineraliza
tion of the cartilage. The pathogenesis of OA is thought to reiterate changes
that occur during endochondral ossiﬁcation in which angiogenesis is
required to initiate chondrocyte hypertrophic differentiation. We previ
ously demonstrated that Bone Sialoprotein (BSP) production is associated
with chondrocyte hypertrophy and the severity of osteoarthritic lesions. In
this work, we investigated the impact of hypertrophic differentiation on
the chondrocytes capacity to promote vascularization. We also speculated
that BSP is a key mediator of cartilage vascularization.
Methods: In alginate beads, OA chondrocytes cultured in the presence of
serum undergo hypertrophic differentiation in long term culture. Using
this model, we tested the effects of hypertrophic chondrocytes condi
tioned medium after 24 hours serum deprivation on the invasion and
migration of endothelial cells using two different models : the real time
follow up of the cells performed with the xCELLigence system (Roche)
and high end microscopic analysis of living endothelial cells in a wound
healing assay. We also studied BSP gene expression (by RT PCR)
and production (by western blot) during chondrocyte hypertrophic
differentiation. The effects of IL 1b (170 pg/ml) and TNFa (25 ng/ml) were
tested on the synthesis of BSP by hypertrophic chondrocytes. These
cytokines were added to the culture medium before (day 7) or after
(day 21) hypertrophic phenotype was reached. Finally, the effect of
increased concentration of recombinant BSP (25 ng/ml to 400 ng/ml) on
the production of a proangiogenic factor, interleukin 8 (IL8) and an
anti angiogenic factor, thrombospondin 1 (TSP1) was studied by
immunoassays.
Results: Hypertrophic OA chondrocytes conditionned medium showed
a higher stimulating effect on endothelial cells migration and invasion
than serum containing medium (positive control). We demonstrated that
BSP gene expression and protein productionwere associated with markers
of hypertrophy collagen type 10 (COL X), alkaline phosphatase (AP),
nucleoside triphosphate pyrophosphohydrolase (NTPPPH) in OA but this
association was not observed in normal chondrocyte cultures. IL 1b or
TNFa in the culture medium decreased gene expression of BSP when
added at day 7 or at day 21 (p<0.05). In the same manner, both cytokines
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protein expression by OA chondrocytes in a dose dependent manner (IL8 :
r¼0.58, p¼0.0047 ; TSP1 : r¼ 0.95, p<0,0001).
Conclusions: Hypertrophic chondrocytes stimulated migration and inva
sion of endothelial cells indicating that hypertrophic chondrocytes
expressed a pro angiogenic phenotype. BSP expression is associated with
hypertrophic differentiation of OA chondrocytes suggesting that it could
be a keymediator of the hypertrophic chondrocytes induced angiogenesis.
This hypothesis is supported by the inhibiting effect of BSP on TSP 1, a anti
angiogenic factor. To control or reverse chondrocyte hypertrophic differ
entiation is a promising way for the treatment of OA. In this context, BSP is
a potential target for drugs.
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AKT PHOSPHORYLATION IN HUMAN CHONDROCYTES IS DOWN
REGULATED VIA P53R2 IN RESPONSE TO MECHANICAL STRESS
K. Kawakita, T. Nishiyama, T. Fujishiro, S. Hayashi, S. Hashimoto,
K. Iwasa, S. Sakata, M. Kurosaka. Kobe Univ. graduate school of medicine,
Kobe, Japan
Purpose: p53 tumor suppressor protein is activated in response to DNA
damage. When the DNA is damaged, Ser15 residue is phosphorylated and
p53R2 is induced. The role of p53R2 in chondcotytes is unknown. In this
study, we evaluated p53R2 expression in chondrocytes in response to
mechanical stress. Furthermore, we investigated the function of p53R2 in
response to mechanical stress.
Methods: OA cartilage samples were obtained from total knee replace
ment surgery, and normal cartilage samples were from femoral neck
fracture. The expression of p53R2 was analyzed by immunohistochem
istry. Chondrocytes were isolated from OA and normal cartilage and
grown. The expression of p53R2 in chondrocytes was detected by western
blotting and real time PCR. Normal and OA chondrocytes were introduced
5% tensile strain using FX 2000. After the strain, expressions of p53R2,
ERK1/2, JNK, Akt, phospho ERK1/2, phospho JNK and phospho Akt were
detected by western blotting respectively. OA chondrocytes after trans
fection of p53R2 siRNA or control siRNA were introduced the same strain.
Expressions of p53R2 and the same protein kinases were detected by
western blotting. Furthermore, glycosaminoglycan(GAG) quantiﬁcation
was performed after the strain.
Results: p53R2 was highly expressed in OA cartilage in comparison with
normal cartilage by immunohistochemistry. Western blotting and real
time PCR showed p53R2 expression in chondrocytes was higher in OA
chondrocytes than normal chondrocytes, too. (Fig.1) p53R2 expression in
OA and normal chondrocytes was increased after 5% tensile strain. On the
other hand, Akt phosphorylation was down regulated after the strain.
However other protein kinases were not regulated signiﬁcantly. (Fig.2)
Akt phosphorylation was up regulated after transfection of p53R2 siRNA.
(Fig.3) GAG was down regulated by the 5% strain, however up regulated
after p53R2 siRNA transfection.
Conclusions: p53R2 could regulate Akt signaling in chondrocyte mecha
notransduction. Down regulation of p53R2 expression might increase
production of glycosaminoglycan. We consider that the regulation of
p53R2 might be a strategy for OA treatment.233
CO INCUBATION OF BOVINE CARTILAGE EXPLANTS WITH JOINT
CAPSULE INCREASES AGGRECAN PROTEOLYSIS, WHILE MECHANICAL
INJURY ALONE DOES NOT AFFECT THE DEGRADATION
M. Hansson 1, P. Swärd 1, S. Lohmander 1,2, S. Byan 3, A. Grodzinsky 3,
A. Struglics 1. 1Dept. of Orthopaedics, Clinical Sci. Lund, Lund Univ., Lund,
Sweden; 2Res. Unit for Musculoskeletal Function and Physiotherapy, and
Dept. of Orthopaedics and Traumatology, Univ. of Southern Denmark,
Odense, Denmark; 3Massachusetts Inst. of Technology, Cambridge, MA, USA
Purpose: Knee injuries are often a gateway to OA. A hallmark of OA is the
destruction of joint cartilage where proteolytic cleavage of aggrecan is an
initiation and progression of the disease. Proteolysis of aggrecan is medi
ated by various enzymes of which aggrecanases and matrix metal
loproteinases (MMPs) are the most important. We analyzed the aggrecan
fragments from bovine cartilage explants where selected groups of spec
imens were ﬁrst subjected to mechanical injury or left uninjured, and then
cultured in the presence or absence of joint capsule (JC).
Methods: Bovine cartilage was harvested from the patellofemoral groove
from a 1 2 week old calf, and six cartilage disks (from six joint surface
